New drug debio 1453P tested in humans for first time
NCT ID NCT07035769
First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This early-phase trial is testing a new drug called Debio 1453P for the first time in humans. The study involves 88 healthy adults aged 18 to 55 who will receive either the drug or a placebo. Researchers are primarily checking if the drug is safe and how the body processes it at different dose levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Debio 1453P
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
SGS Belgium NV - Clinical Pharmacology Unit
RECRUITINGEdegem, 2650, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates